Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > AACR - late breaking absracts text posted by noon today

<< Previous

Bullboard Posts

Next >>

Comment by PWIB123on Apr 15, 2023 9:48am

128 Views

Post# 35396563

RE:RE:RE:RE:RE:RE:AACR - late breaking absracts text posted by noon today

Another reason why I'm voting against all of them, again, and all of their proposals. Let's be honest, if we all vote no, it won't change the leadership, but at some point, they have to start paying attention to investor needs. I want them worried about one of the larger investors deciding to move against them and the outright abismal results they get from the annual shareholder meeting, proving how disatsfied we investors are.

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages